Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) [Phase 1]

View source ↗

Summary

A Phase 1 study from Hoffmann-La Roche evaluating targeted therapies in subpopulations of metastatic colorectal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: RECRUITING